Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Safety Issues
  • Tolerance
Type
Interventional
Phase
Not Applicable
Design
Allocation: Non-RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: Dose escalating cross over trialMasking: None (Open Label)Primary Purpose: Other

Participation Requirements

Age
Between 70 years and 85 years
Gender
Both males and females

Description

The tolerability to 10 g, 20 g, and 30 g of soy will be tested. At each dose, eight subjects will incorporate the foods containing soy into their usual diet for one week. The tolerability to each dose will be evaluated and fecal short chain fatty acids will be measured as a biomarker of compliance. ...

The tolerability to 10 g, 20 g, and 30 g of soy will be tested. At each dose, eight subjects will incorporate the foods containing soy into their usual diet for one week. The tolerability to each dose will be evaluated and fecal short chain fatty acids will be measured as a biomarker of compliance. Subjects who satisfy the eligibility criteria and express willingness to consume the study foods will be enrolled.

Tracking Information

NCT #
NCT04499482
Collaborators
National Institute on Aging (NIA)
Investigators
Principal Investigator: Candida Rebello, Ph.D. Pennington Biomedical Research Center